Poster Session III (Abstracts 1195 – 1637)

Autor:	Wisut Lamlertthon, Edward Gane, Josep M. Llovet, Baek-Yeol Ryoo, Thomas Yau, Watana Sukeepaisarnjaroen, Yuk Ting Ma, Judit Kocsis, Jean-François Dufour, René Gerolami, Winnie Yeo, Jean-Frédéric Blanc, Philippe Merle, Markus Peck-Radosavljevic, Su Pin Choo, Karl Heinz Weiss, Heiko Krissel, Satawat Thongsawat, Vincenzo Mazzaferro, Paul Ross, Chia Jui Yen, Thong Dao, Ho Yeong Lim, Michael Teufel
Rok vydání:	2016
Předmět:	Sorafenib Hepatology business.industry Mutant RAS medicine.disease 030226 pharmacology & pharmacy 03 medical and health sciences 0302 clinical medicine Hepatocellular carcinoma Cancer research medicine 030211 gastroenterology & hepatology In patient Refametinib business medicine.drug
Zdroj:	Hepatology. 64:601-810
ISSN:	1527-3350 0270-9139
DOI:	10.1002/hep.28799
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::e44c5829f074daaf2b5027d5b187969f https://doi.org/10.1002/hep.28799 Zobrazit plný text záznamu Plný text